SK5792003A3 - Methods for large scale production of recombinant DNA-derived tPA or K2S molecules - Google Patents

Methods for large scale production of recombinant DNA-derived tPA or K2S molecules Download PDF

Info

Publication number
SK5792003A3
SK5792003A3 SK579-2003A SK5792003A SK5792003A3 SK 5792003 A3 SK5792003 A3 SK 5792003A3 SK 5792003 A SK5792003 A SK 5792003A SK 5792003 A3 SK5792003 A3 SK 5792003A3
Authority
SK
Slovakia
Prior art keywords
dna
leu
ser
gly
variant
Prior art date
Application number
SK579-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Rolf-Gunther Werner
Friedrich Goetz
Chatchai Tayapiwatana
Jiradej Manosroi
Aranya Manosroi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SK5792003A3 publication Critical patent/SK5792003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK579-2003A 2000-11-14 2001-11-07 Methods for large scale production of recombinant DNA-derived tPA or K2S molecules SK5792003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027779.8A GB0027779D0 (en) 2000-11-14 2000-11-14 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
PCT/EP2001/012857 WO2002040650A2 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant dna-derived tpa or k2s molecules

Publications (1)

Publication Number Publication Date
SK5792003A3 true SK5792003A3 (en) 2004-01-08

Family

ID=9903153

Family Applications (1)

Application Number Title Priority Date Filing Date
SK579-2003A SK5792003A3 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant DNA-derived tPA or K2S molecules

Country Status (31)

Country Link
EP (1) EP1407030B1 (cs)
JP (1) JP2004520018A (cs)
KR (1) KR100856346B1 (cs)
CN (1) CN100567495C (cs)
AR (1) AR031334A1 (cs)
AT (1) ATE504652T1 (cs)
AU (2) AU2002221815B2 (cs)
BG (1) BG66121B1 (cs)
BR (1) BR0115344A (cs)
CA (1) CA2428642C (cs)
CZ (1) CZ20031657A3 (cs)
DE (1) DE60144395D1 (cs)
EA (1) EA005163B1 (cs)
EC (1) ECSP034573A (cs)
EE (1) EE200300232A (cs)
GB (1) GB0027779D0 (cs)
HR (1) HRP20030377A2 (cs)
HU (1) HUP0301619A3 (cs)
IL (2) IL155568A0 (cs)
MX (1) MXPA03004161A (cs)
MY (1) MY129838A (cs)
NO (1) NO20032143L (cs)
NZ (1) NZ526280A (cs)
PL (1) PL206783B1 (cs)
SK (1) SK5792003A3 (cs)
TW (1) TWI292782B (cs)
UA (1) UA75102C2 (cs)
UY (1) UY27020A1 (cs)
WO (1) WO2002040650A2 (cs)
YU (1) YU36103A (cs)
ZA (1) ZA200303547B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
IL190184A0 (en) 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
WO1998054199A1 (en) * 1997-05-28 1998-12-03 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
GB0027782D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes

Also Published As

Publication number Publication date
JP2004520018A (ja) 2004-07-08
CA2428642C (en) 2010-03-30
NO20032143L (no) 2003-07-07
CN1541271A (zh) 2004-10-27
NZ526280A (en) 2006-02-24
CN100567495C (zh) 2009-12-09
AU2181502A (en) 2002-05-27
BG66121B1 (bg) 2011-05-31
EE200300232A (et) 2003-10-15
EP1407030A2 (en) 2004-04-14
AR031334A1 (es) 2003-09-17
AU2002221815B2 (en) 2007-08-23
PL361881A1 (en) 2004-10-04
IL155568A0 (en) 2003-11-23
WO2002040650A2 (en) 2002-05-23
HUP0301619A3 (en) 2006-11-28
DE60144395D1 (de) 2011-05-19
CZ20031657A3 (cs) 2003-10-15
EA200300502A1 (ru) 2003-12-25
HRP20030377A2 (en) 2005-04-30
GB0027779D0 (en) 2000-12-27
CA2428642A1 (en) 2002-05-23
WO2002040650A3 (en) 2003-12-31
UY27020A1 (es) 2002-07-31
ECSP034573A (es) 2003-05-26
PL206783B1 (pl) 2010-09-30
YU36103A (sh) 2006-05-25
BR0115344A (pt) 2003-08-26
BG107780A (bg) 2004-02-27
EP1407030B1 (en) 2011-04-06
KR100856346B1 (ko) 2008-09-04
MXPA03004161A (es) 2004-04-20
ZA200303547B (en) 2004-05-10
EA005163B1 (ru) 2004-12-30
ATE504652T1 (de) 2011-04-15
HUP0301619A2 (hu) 2003-09-29
KR20030059252A (ko) 2003-07-07
TWI292782B (en) 2008-01-21
HK1070097A1 (zh) 2005-06-10
MY129838A (en) 2007-05-31
UA75102C2 (en) 2006-03-15
NO20032143D0 (no) 2003-05-13
IL155568A (en) 2010-02-17

Similar Documents

Publication Publication Date Title
KR100188302B1 (ko) 활성화피브린용해성과항-혈전성단백질
JP5539896B2 (ja) 組換え的に改変されたプラスミン
JPH0698002B2 (ja) ヒトプロティンc活性の発現ベクター
ES2332124T3 (es) Metodo para la produccion a gran escala del dominio kringle 2 mas serina proteasa (k2s) de plasminogeno en procariotas.
US7087412B2 (en) Methods for large scale protein production in prokaryotes
US6955910B2 (en) Method for large scale production of recombinant DNA-derived TPA or K2S molecules
JP2589687B2 (ja) ハイブリドプラスミノーゲンアクチベーター様ポリペプチド
KR100856346B1 (ko) 재조합체 DNA-유도된 tPA 또는 K2S 분자의 대규모제조 방법
US20100015123A1 (en) Novel thrombolytic molecules and a process therefor
Chiron et al. Pseudomonas exotoxin exhibits increased sensitivity to furin when sequences at the cleavage site are mutated to resemble the arginine‐rich loop of diphtheria toxin
AU2002221815A1 (en) Methods for large scale production of recombinant DNA-derived tPA or K2S molecules
JP3061199B2 (ja) エリトリナ・カッフラ型インヒビターの突然変異体及びセリンプロテアーゼを精製するための前記突然変異体の利用
HK1070097B (en) Methods for large scale production of recombinant dna-derived tpa or k2s molecules
CA2185436C (en) Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases
HK1077848B (en) Methods for large scale protein production in prokaryotes

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure